Investor Acacia Research Corp
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Acacia Research Corp . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2022-06-29 13D/A SPOK / Spok Holdings, Inc. 1,261,883 966,883
2021-08-30 13D SPOK / Spok Holdings, Inc. 1,261,883
2020-06-11 13G TBPH / Theravance Biopharma, Inc. 0
2020-06-09 13G EVFM / Evofem Biosciences, Inc. 1,000
2020-03-10 13D/A VERI / Veritone, Inc. 1,526,629 1,120,432
2019-12-26 13D/A IMMR / Immersion Corporation 1,619,397 1,533,991
2019-08-01 13D IMMR / Immersion Corporation 1,619,397
2019-07-29 13D/A VERI / Veritone, Inc. 1,775,214 1,526,629
2019-04-09 13D/A VERI / Veritone, Inc. 1,911,904 1,775,214
2019-03-07 13D/A VERI / Veritone, Inc. 2,005,204 1,911,904
2019-01-15 13D/A VERI / Veritone, Inc. 2,539,952 2,005,204
2018-12-17 13D/A VERI / Veritone, Inc. 2,739,952 2,539,952
2018-12-06 13D/A VERI / Veritone, Inc. 4,239,952 2,739,952
2018-08-31 13D VERI / Veritone, Inc. 4,239,952